Predictions
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.34
12.09.22
12.09.22
-
12.09.23
12.09.23
-93.70%
02.04.23
02.04.23
Could be very worthwhile Investment >20% year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€11.50
09.09.22
09.09.22
-
09.09.23
09.09.23
266.96%
18.05.23
18.05.23
Risky Investment
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€60.00
08.09.22
08.09.22
€80.00
31.12.24
31.12.24
35.00%
24.06.23
24.06.23
Could be very worthwhile Investment >20% year
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€25.60
08.09.22
08.09.22
€40.00
31.12.24
31.12.24
35.94%
21.10.22
21.10.22
Could be very worthwhile Investment >20% year
Ardelyx Inc.
Start price
Target price
Perf. (%)
€1.29
08.09.22
08.09.22
€2.00
31.12.24
31.12.24
31.25%
09.12.22
09.12.22
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€64.19
07.09.22
07.09.22
€35.00
31.12.24
31.12.24
8.24%
29.09.22
29.09.22
Could be very worthwhile Investment >20% year
Seagen Inc.
Start price
Target price
Perf. (%)
€152.08
07.09.22
07.09.22
€180.00
31.12.24
31.12.24
21.00%
21.03.23
21.03.23
Could be very worthwhile Investment >20% year
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€104.00
07.09.22
07.09.22
€180.00
31.12.25
31.12.25
41.35%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€69.37
07.09.22
07.09.22
€100.00
31.12.25
31.12.25
-12.07%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€285.85
07.09.22
07.09.22
€400.00
31.12.25
31.12.25
10.34%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€312.95
07.09.22
07.09.22
€450.00
31.12.25
31.12.25
24.24%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€74.46
07.09.22
07.09.22
€100.00
31.12.24
31.12.24
-29.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Biogen Inc.
Start price
Target price
Perf. (%)
€199.36
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
36.69%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€208.80
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
14.70%
13.09.24
13.09.24
Could be very worthwhile Investment >20% year
Celldex Therapeutics
Start price
Target price
Perf. (%)
€29.80
07.09.22
07.09.22
€50.00
31.12.25
31.12.25
26.85%
12.09.24
12.09.24
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
07.09.22
07.09.22
€80.00
31.12.24
31.12.24
-29.90%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Horizon Pharma plc
Start price
Target price
Perf. (%)
€61.22
07.09.22
07.09.22
€100.00
31.12.25
31.12.25
73.41%
14.12.22
14.12.22
Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€37.60
07.09.22
07.09.22
€50.00
31.12.24
31.12.24
-5.32%
12.09.24
12.09.24
Could be very worthwhile Investment >20% year
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€0.81
07.09.22
07.09.22
€2.00
31.12.24
31.12.24
72.58%
09.12.22
09.12.22
Could be very worthwhile Investment >20% year
Kezar Life Sciences
Start price
Target price
Perf. (%)
€9.70
07.09.22
07.09.22
€20.00
31.12.24
31.12.24
-76.29%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€4.55
06.09.22
06.09.22
-
06.09.23
06.09.23
-53.45%
06.09.23
06.09.23
Valneva SE
Start price
Target price
Perf. (%)
€8.01
05.09.22
05.09.22
-
05.10.26
05.10.26
-57.57%
11.03.24
11.03.24
Probably not worthwhile Investment
MorphoSys AG
Start price
Target price
Perf. (%)
€16.57
05.09.22
05.09.22
-
05.10.26
05.10.26
293.97%
11.03.24
11.03.24
Probably not worthwhile Investment
Novacyt S.A.
Start price
Target price
Perf. (%)
€1.06
05.09.22
05.09.22
-
05.09.23
05.09.23
-46.97%
24.04.23
24.04.23
Probably not worthwhile Investment